340B

Oct 31, 2018
The Department of Health and Human Services today proposed implementing on Jan. 1 its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers.
Sep 18, 2018
Leaders from the AHA and individual 340B hospitals today came together to announce new principles for ensuring good stewardship of the 340B program. The new AHA-led initiative seeks to strengthen the 340B program by increasing transparency while helping 340B hospitals better publicly communicate…
May 4, 2020
A panel of 4 experts discussed federal policy emerging from Congress and the Administration under COVID-19 focusing on rural health priorities and took questions from the audience. They reviewed emergency funding, Medicare and Medicaid payment improvements, telehealth, regulatory relief, 340B drug…
Apr 21, 2020
The AHA urged the Department of Health and Human Services and the Health Resources and Services Administration to provide flexibility in the administration of the 340B Drug Pricing Program to better enable these hospitals to serve their communities during the COVID-19 national emergency.
Mar 10, 2020
The AHA submitted its comments to the Office of Management and Budget regarding the Centers for Medicare & Medicaid Services (CMS) plans to collect pricing data on Hospital Survey for Specified Covered Outpatient Drugs (SCODs) from all hospitals that participate in the 340B Drug Pricing Program.
Mar 5, 2020
Model comment letter regarding CMS–10709, Hospital Survey for Specified Covered Outpatient Drugs; Agency Information Collection Activities: Proposed Collection; Comment Request (Vol. 85, No. 26), February 7, 2020.
Jan 28, 2020
For more than 25 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription drug costs. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for…
Jan 10, 2020
The Health Resources and Services Administration should increase its oversight of private nonprofit hospitals that participate in the 340B drug savings program to ensure they meet eligibility requirements, the Government Accountability Office said in a report released today.
Dec 19, 2019
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec lacus justo, scelerisque ut orci vitae, venenatis dignissim sapien. In vitae enim quis purus euismod euismod nec in nibh. Donec hendrerit lectus lacus, quis elementum justo tristique vitae.
Dec 19, 2019
The pharmaceutical industry’s latest “report” is an obvious attempt to divert attention away from a problem of their own making: skyrocketing drug prices.